SG Americas Securities
SIOX

SG Americas Securities’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

SG Americas Securities’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,579
Closed -$47K – 3541
2018
Q2 		$47K Sell
2,579
-2,752
-52% -$40.6K ﹤0.01% 3182
2018
Q1 		$57K Buy
+5,331
New +$85.6K ﹤0.01% 3059
2016
Q4 		– Sell
-1,109
Closed -$124K – 3563
2016
Q3 		$124K Buy
+1,109
New +$133K ﹤0.01% 2894
2015
Q4 		– Sell
-31,161
Closed -$3.22M – 3056
2015
Q3 		$3.22M Buy
31,161
+29,350
+1,621% +$3.44M 0.02% 482
2015
Q2 		$295K Buy
+1,811
New +$307K ﹤0.01% 1784

Other funds holding SIOX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

SG Americas Securities's SIOX Position: Q3 2018 in Review

SG Americas Securities sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2018, closing a stake of 2,579 shares — an estimated $47K sold.

SG Americas Securities first reported a position in SIOX in Q2 2015 and held it in 5 quarters. The position peaked at $3.22M in Q3 2015. 61 funds tracked by Wall St. Rank hold SIOX as of Q3 2018.

  • SG Americas Securities reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • SG Americas Securities sold 2,579 Sio Gene Therapies Inc. Common Stock shares in Q3 2018, an estimated $47K.
  • SG Americas Securities first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 5 quarters.
  • SG Americas Securities's Sio Gene Therapies Inc. Common Stock position peaked at $3.22M in Q3 2015.
  • 61 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2018.

Based on SG Americas Securities's 13F filing for Q3 2018, filed 6 Nov 2018.